In an effort to reallocate resources to its growing oncology focus in the face of shrinking COVID-19 vaccine sales, German ...

Pfizer is also demonstrating that its commercial portfolio can flourish beyond the historically mammoth sales of its COVID-19 ...

Novartis is continuing its multiyear overhaul with new plans to shutter its production facility in Wehr, Germany. | Novartis ...

Fresh off gaining an FDA expansion for Auvelity as a treatment for Alzheimer’s disease agitation (ADA), Axsome Therapeutics ...

The California-based biotech has hired Omeros and AbbVie alum Nadia Dac as its new chief commercial officer, where she will ...

Though largely operating in the background until recently, Prolific Machines’ optogenetic approach to biomanufacturing is set ...

Sanofi is supercharging its artificial intelligence capabilities. | Sanofi is supercharging its artificial intelligence ...

Created from the merger of Mallinckrodt and Endo last year, Keenova is launching the first Dupuytren's contracture campaign ...

Robert Blum and Fady Malik, M.D., Ph.D, have been with Cytokinetics since its inception nearly three decades ago. | ...

Neurocrine Biosciences has shared survey data showing how tardive dyskinesia (TD) affects the ability of patients and ...

After submitting plans to cut 114 jobs tied to its U.S. headquarters in New Jersey in March, Novartis late last month added a ...

The U.S. Supreme Court has temporarily reinstated online access to the abortion pill mifepristone.  | The U.S. Supreme Court ...